Average Insider

Where insiders trade, we follow

Collins Helen Louise

CHIEF MEDICAL OFFICER
CIK: 1701247

All Transactions

DateCompanyTypeSharesPriceValueActions
Mar 17, 2026Enliven Therapeutics, Inc. (ELVN)S5,000$27.76$138,800.00View Details Filing
Mar 17, 2026Enliven Therapeutics, Inc. (ELVN)M5,000$2.48$12,400.00View Details Filing
Mar 17, 2026Enliven Therapeutics, Inc. (ELVN)M5,000$0.00$0.00View Details Filing
Mar 10, 2026Enliven Therapeutics, Inc. (ELVN)S10,129$30.19$305,826.92View Details Filing
Mar 10, 2026Enliven Therapeutics, Inc. (ELVN)M10,129$2.48$25,119.92View Details Filing
Mar 10, 2026Enliven Therapeutics, Inc. (ELVN)M10,129$0.00$0.00View Details Filing
Mar 9, 2026Enliven Therapeutics, Inc. (ELVN)M29,871$0.00$0.00View Details Filing
Mar 9, 2026Enliven Therapeutics, Inc. (ELVN)M29,871$2.48$74,080.08View Details Filing
Mar 9, 2026Enliven Therapeutics, Inc. (ELVN)S29,871$30.02$896,811.06View Details Filing
Feb 17, 2026Enliven Therapeutics, Inc. (ELVN)M45,000$2.48$111,600.00View Details Filing
Feb 17, 2026Enliven Therapeutics, Inc. (ELVN)S45,000$26.17$1,177,861.50View Details Filing
Feb 17, 2026Enliven Therapeutics, Inc. (ELVN)M45,000$0.00$0.00View Details Filing
Feb 12, 2026Enliven Therapeutics, Inc. (ELVN)A150,000$0.00$0.00View Details Filing
Feb 12, 2026Enliven Therapeutics, Inc. (ELVN)A25,000$0.00$0.00View Details Filing
Version: v26.3.23